Bicara Therapeutics Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
BCAX on Nasdaq
Location
245 Main Street, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Bicara Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other* Sep 16, 2024
Kate Haviland Director Sep 12, 2024
Scott M. Robertson Director Sep 12, 2024
Biocon Ltd 10%+ Owner Sep 16, 2024
Carolyn Ng Director Sep 12, 2024
Nils Lonberg Director Sep 12, 2024
James E. Flynn Possible Members of 10% Group, 10%+ Owner Sep 17, 2024
Ryan Cohlhepp President and COO Sep 12, 2024
Claire Mazumdar Chief Executive Officer, Director Sep 12, 2024
Christopher Bowden Director Sep 12, 2024
Kiran Mazumdar-Shaw Director, 10%+ Owner Sep 12, 2024
David Raben Chief Medical Officer Sep 12, 2024
Michael Powell Director Sep 12, 2024
Ivan Hyep Chief Financial Officer Sep 12, 2024
Lara Meisner Chief Legal Officer Sep 12, 2024
Jake Simson Director Sep 12, 2024
Ra Capital Management, L.P. Director, 10%+ Owner Sep 16, 2024
FIL Ltd Other* Sep 16, 2024
Tpg Gp A, Llc Former 10% Owner Sep 16, 2024

Recent Insider Transactions by Companies or Individuals for Bicara Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.